EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Role of Novel Therapeutics

Sayantani B Sindher, Eimear O'Rourke, William Tan, Andrew R Chin, R Sharon Chinthrajah

Immunology and Allergy Clinics of North America · 2025

DOI: 10.1016/j.iac.2025.04.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2025. Verfasst von Sayantani B Sindher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94304, USA. Electronic address: tin…. Hauptthemen laut MEDLINE: Food Hypersensitivity, Anti-Allergic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent United States Food and Drug Administration (FDA) approval of omalizumab for the treatment of food allergy has highlighted the potential of targeting the allergic pathways driving food allergy. Many promising therapeutic strategies are emerging that target different aspects of these pathways including immunoglobulin E, interleukin-4 receptor α, alarmins, and Bruton's tyrosine kinase. Several of these novel therapeutics have already been FDA approved for the treatment of other atopic diseases, greatly facilitating their potential translation to food allergy. Further research on these therapeutics can expand the tools available to allergists allowing them to better tailor therapeutics to the specific circumstances and needs of their patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityAnti-Allergic AgentsHumansImmunoglobulin EAnimalsOmalizumabAgammaglobulinaemia Tyrosine Kinase

Stichwörter der Autor:innen

BiologicsClinical trialsFood allergyTherapeutics

Substanzen

Immunoglobulin EAnti-Allergic AgentsOmalizumabAgammaglobulinaemia Tyrosine Kinase

Autor:innen und Institutionen

  • Department of Pathology, Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94304, USA. Electronic address: tina.sindher@stanford.edu.
  • Department of Pathology, Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94304, USA; Ulster Hospital, Upper Newtownards Road, Dundonald, Belfast BT16 1RH, UK.
  • Department of Pathology, Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, CA 94304, USA.

Zitieren

APA

Sindher, S. B., O'Rourke, E., Tan, W., Chin, A. R., & Chinthrajah, R. S. (2025). Emerging Role of Novel Therapeutics. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2025.04.008

Vancouver

Sindher SB, O'Rourke E, Tan W, Chin AR, Chinthrajah RS. Emerging Role of Novel Therapeutics. Immunology and Allergy Clinics of North America. 2025. doi:10.1016/j.iac.2025.04.008

BibTeX
@article{Sindher2025,
  author = {Sindher, Sayantani B and O'Rourke, Eimear and Tan, William and Chin, Andrew R and Chinthrajah, R Sharon},
  title = {Emerging Role of Novel Therapeutics},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2025},
  doi = {10.1016/j.iac.2025.04.008}
}
Kostenlos starten →